rs6546837
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001378454.1(ALMS1):c.4244G>A(p.Gly1415Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1415A) has been classified as Benign.
Frequency
Consequence
NM_001378454.1 missense
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 42
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
ALMS1-related disorder Uncertain:1
The ALMS1 c.4247G>A variant is predicted to result in the amino acid substitution p.Arg1416Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.047% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-73677904-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at